Agilent Technologies Inc (A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Agilent Technologies Inc (A) has a cash flow conversion efficiency ratio of 0.057x as of July 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($362.00 Million) by net assets ($6.37 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Agilent Technologies Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Agilent Technologies Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Agilent Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Agilent Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Dtech Technology Co. Ltd. A
SHE:301377
|
N/A |
|
Powszechna Kasa Oszczednosci Bank Polski SA
WAR:PKO
|
0.131x |
|
Coinbase Global Inc
NASDAQ:COIN
|
0.014x |
|
Telefonaktiebolaget LM Ericsson (publ)
ST:ERIC-B
|
0.077x |
|
Heineken
AS:HEIA
|
0.161x |
|
Keysight Technologies Inc
NYSE:KEYS
|
0.038x |
|
Nucor Corp
NYSE:NUE
|
0.061x |
|
JD.com Inc.
F:013C
|
-0.026x |
Annual Cash Flow Conversion Efficiency for Agilent Technologies Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Agilent Technologies Inc from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Agilent Technologies Inc (A) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | $6.74 Billion | $1.56 Billion | 0.231x | -22.10% |
| 2024-10-31 | $5.90 Billion | $1.75 Billion | 0.297x | -2.07% |
| 2023-10-31 | $5.84 Billion | $1.77 Billion | 0.303x | +22.58% |
| 2022-10-31 | $5.30 Billion | $1.31 Billion | 0.247x | -10.25% |
| 2021-10-31 | $5.39 Billion | $1.49 Billion | 0.276x | +45.80% |
| 2020-10-31 | $4.87 Billion | $921.00 Million | 0.189x | -12.11% |
| 2019-10-31 | $4.75 Billion | $1.02 Billion | 0.215x | -9.57% |
| 2018-10-31 | $4.57 Billion | $1.09 Billion | 0.238x | +29.33% |
| 2017-10-31 | $4.83 Billion | $889.00 Million | 0.184x | -1.60% |
| 2016-10-31 | $4.24 Billion | $793.00 Million | 0.187x | -41.23% |
| 2015-10-31 | $4.16 Billion | $1.32 Billion | 0.318x | +135.76% |
| 2014-10-31 | $5.29 Billion | $713.00 Million | 0.135x | -38.08% |
| 2013-10-31 | $5.29 Billion | $1.15 Billion | 0.218x | -8.03% |
| 2012-10-31 | $5.18 Billion | $1.23 Billion | 0.237x | -18.87% |
| 2011-10-31 | $4.32 Billion | $1.26 Billion | 0.292x | +32.68% |
| 2010-10-31 | $3.24 Billion | $712.00 Million | 0.220x | +35.14% |
| 2009-10-31 | $2.51 Billion | $408.00 Million | 0.163x | -44.89% |
| 2008-10-31 | $2.56 Billion | $756.00 Million | 0.295x | -1.40% |
| 2007-10-31 | $3.23 Billion | $969.00 Million | 0.300x | +72.92% |
| 2006-10-31 | $3.66 Billion | $634.00 Million | 0.173x | -21.34% |
| 2005-10-31 | $4.08 Billion | $899.00 Million | 0.220x | +17.35% |
| 2004-10-31 | $3.57 Billion | $670.00 Million | 0.188x | +468.15% |
| 2003-10-31 | $2.82 Billion | $-144.00 Million | -0.051x | +52.62% |
| 2002-10-31 | $4.63 Billion | $-498.00 Million | -0.108x | -140.55% |
| 2001-10-31 | $5.66 Billion | $1.50 Billion | 0.265x | +66.76% |
| 2000-10-31 | $5.26 Billion | $838.00 Million | 0.159x | +16.77% |
| 1999-10-31 | $3.38 Billion | $461.00 Million | 0.136x | -45.15% |
| 1998-10-31 | $3.02 Billion | $751.00 Million | 0.249x | -- |
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more